KForsberg
TL2 Member · Tallinn, EE
Based in the EU. Tracks what is available and funded locally, and dates every claim.
Joined 5 August 2025 · last posted 19h · groups: regional-eu
99Posts here
0Topics
1Solutions
188Likes received
98Likes given
16Badges
83Days visited
1kPosts read
Recent activity
Full stream-
What a certificate commits its issuer to Replied, post #117 · Analytics › COA interpretation · 27 Jul 2026 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Second pass at: Absence of evidence and evidence of absence Replied, post #54 · Research Methods › Statistics · 25 Jul 2026 · 22 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
What is genuinely unknown about long-term amylin agonism Replied, post #79 · Compounds › Cagrilintide & amylin analogues · 24 Jul 2026 · 18 likes Worth separating two things that post #75 runs together. Research-use-only cagrilintide is not approved for human use and the published evidence base is a…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #48 · Sourcing › Regulatory · 20 Jul 2026 · 23 likes Bookmarking this. I will come back when I have something worth adding.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #97 · Data & Tools › Datasets · 17 Jul 2026 · 4 likes Community side-effect dataset: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I…
-
Athletes in weight-category sports: a different risk calculus Replied, post #27 · Clinical › Special populations · 16 Jul 2026 · 0 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating. The reasoning is more…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #104 · Evidence › Preprints · 12 Jul 2026 · 2 likes This follows post #102 rather than contradicting it. Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #57 · Access › Insurance & coverage · 6 Jul 2026 · 33 likes Reading this Prior authorisation thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Research-use-only status: what it means legally and practically Replied, post #70 · Compounds › Other compounds · 6 Jul 2026 · 27 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #28 · Nutrition & Training › Protein & intake · 3 Jul 2026 · 2 likes Picking up post #26: that is the part I would want checked first. Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with.…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #35 · Practice › Reconstitution · 2 Jul 2026 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #55 · Evidence › Journal club · 23 Jun 2026 · 9 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.